Skip to main content
ConductScienceScienceDex

Holly Gwen Prigerson

NIH Rank #3954
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1882697Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2025 award categories

  • Radiology
  • Internal Medicine

NIH Funding · FY2025

Linked Award Amount
$2.8M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#3,954
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Holly Gwen Prigerson. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Holly Gwen Prigerson as a PI. Multi-PI records show the full award amount for context.

  • 5R35CA197730-11R35
    Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study)
    Weill Cornell Medicine
    $982.1K
    award amount
  • 5R01NR021159-02R01
    Bridge to Better End-of-Life Care for Patients with Cancer: Connecting Healthcare Chaplains with Spiritual Care Providers in Faith Communities
    Weill Cornell Medicine
    $789.9K
    award amount
  • 5R01NR019831-04R01
    A Multisite Randomized Controlled Trial of EMPOWER for Family Surrogates of Critically Ill Patients
    Weill Cornell Medicine
    $773.6K
    award amount
  • 5R21MD017652-02R21
    Pilot Trial of a "Divine Intervention" to Improve End-of-Life Cancer Care for Black Patients
    Weill Cornell Medicine
    $209.1K
    award amount

Award organization

Organizations that administered FY2025 awards listing Holly Gwen Prigerson as a PI.

FY2025 award administered by Weill Cornell Medicine (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2950
  6. 2024
    Entered Top 25% Nationally
    Ranked #2950
  7. 2024
    R01 Grant Holder
  8. 2025
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Holly Gwen Prigerson.

Paul K MacIejewski
Weill Cornell Medicine
3
shared awards
Alan Bennett Astrow
Weill Cornell Medicine
2
shared awards
Wendy G. Lichtenthal
Weill Cornell Medicine
2
shared awards
Francesca Falzarano
Weill Cornell Medicine
1
shared award

Explore further

Find collaborators for Holly Gwen Prigerson

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →